$2.15
-0.06-2.71%
At Close: -
$2.21
0.062.74%
After Hours: Aug 22, 5:13 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Immix Biopharma in recent months.
Browse guidance and forecast on all stocks.